Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 52.13B 57.06B 7.27B 6.25B 5.85B 5.33B 9.96B 625B 11.16B 69.21B 26.59B 288B 27.27B 26.69B 1,052B P/E ratio 2025 *
20.2x
P/E ratio 2026 * 16.2x
Enterprise value 46.15B 50.51B 6.43B 5.53B 5.18B 4.72B 8.82B 553B 9.88B 61.26B 23.54B 255B 24.14B 23.63B 931B EV / Sales 2025 *
6.47x
EV / Sales 2026 * 4.91x
Free-Float
42.68%
Yield 2025 *
2.3%
Yield 2026 * 2.85%
More valuation ratios * Estimated data
Dynamic Chart
1 day-5.29%
1 week-2.48%
Current month-28.10%
1 month-30.64%
3 months-22.65%
6 months+1.59%
Current year+2.30%
More quotes
1 week 48.6
Extreme 48.6
56.85
1 month 48.6
Extreme 48.6
74.85
Current year 45.2
Extreme 45.2
87.1
1 year 35
Extreme 35
87.1
3 years 24.3
Extreme 24.3
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 20/04/2022
Director of Finance/CFO 38 20/04/2022
Corporate Secretary 29 30/09/2018
Director TitleAgeSince
Chairman 58 20/04/2022
Director/Board Member 54 29/11/2021
Director/Board Member 66 05/10/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-5.57%-2.48%+13.44% - 6.9B
-0.42%+1.16%-4.80%+11.09% 378B
-0.17%-1.04%+3.00%+22.29% 154B
-0.55%-0.51%-10.92%+9.70% 71.86B
-0.53%-2.81%-7.33%-1.77% 61.73B
-0.84%-1.17%+12.12% - 41.03B
+0.79%-1.46%-23.74%+10.33% 27.31B
+0.31%-0.15%-6.16%-0.72% 18.6B
+0.24%-1.82%-14.99%+47.73% 13.83B
+1.63%+0.65%-20.78%-6.80% 9.58B
Average -0.40%-2.06%-6.02%+11.48% 78.24B
Weighted average by Cap. +0.04%-0.15%-4.05%+12.35%
See all sector performances

Financials

2025 *2026 *
Net sales 7.14B 7.81B 995M 856M 801M 730M 1.36B 85.55B 1.53B 9.48B 3.64B 39.42B 3.73B 3.66B 144B 9.09B 9.95B 1.27B 1.09B 1.02B 930M 1.74B 109B 1.95B 12.06B 4.63B 50.18B 4.75B 4.65B 183B
Net income 2.53B 2.77B 353M 304M 284M 259M 484M 30.36B 542M 3.36B 1.29B 13.99B 1.32B 1.3B 51.11B 3.16B 3.46B 441M 379M 355M 324M 604M 37.91B 677M 4.2B 1.61B 17.47B 1.65B 1.62B 63.83B
Net Debt -5.98B -6.55B -834M -717M -671M -612M -1.14B -71.7B -1.28B -7.94B -3.05B -33.04B -3.13B -3.06B -121B -7.56B -8.27B -1.05B -906M -848M -773M -1.44B -90.56B -1.62B -10.03B -3.85B -41.73B -3.95B -3.87B -152B
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
1,758
More about the company
Date Price Change Volume
25/06/25 50.90 $ -5.57% 8,732,942
24/06/25 53.90 $ +5.27% 37,401,470
23/06/25 51.20 $ -0.10% 12,441,280
20/06/25 51.25 $ +1.99% 12,421,300
19/06/25 50.25 $ -4.01% 12,116,240

Delayed Quote Hong Kong S.E., June 25, 2025 at 03:20 am

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
53.90HKD
Average target price
81.68HKD
Spread / Average Target
+51.54%
Consensus

Quarterly revenue - Rate of surprise